Literature DB >> 33499170

The Role of H3K4 Trimethylation in CpG Islands Hypermethylation in Cancer.

Giuseppe Zardo1.   

Abstract

CpG methylation in transposons, exons, introns and intergenic regions is important for long-term silencing, silencing of parasitic sequences and alternative promoters, regulating imprinted gene expression and determining X chromosome inactivation. Promoter CpG islands, although rich in CpG dinucleotides, are unmethylated and remain so during all phases of mammalian embryogenesis and development, except in specific cases. The biological mechanisms that contribute to the maintenance of the unmethylated state of CpG islands remain elusive, but the modification of established DNA methylation patterns is a common feature in all types of tumors and is considered as an event that intrinsically, or in association with genetic lesions, feeds carcinogenesis. In this review, we focus on the latest results describing the role that the levels of H3K4 trimethylation may have in determining the aberrant hypermethylation of CpG islands in tumors.

Entities:  

Keywords:  DNA hypermethylation; H3K4 trimethylation; acute myeloid leukemia; cancer

Year:  2021        PMID: 33499170      PMCID: PMC7912453          DOI: 10.3390/biom11020143

Source DB:  PubMed          Journal:  Biomolecules        ISSN: 2218-273X


  216 in total

1.  Hypermethylation of the CpG island of p16/CDKN2 correlates with gene inactivation in gliomas.

Authors:  J Fueyo; C Gomez-Manzano; J M Bruner; Y Saito; B Zhang; W Zhang; V A Levin; W K Yung; A P Kyritsis
Journal:  Oncogene       Date:  1996-10-17       Impact factor: 9.867

2.  High expression of the DNA methyltransferase gene characterizes human neoplastic cells and progression stages of colon cancer.

Authors:  W S el-Deiry; B D Nelkin; P Celano; R W Yen; J P Falco; S R Hamilton; S B Baylin
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

3.  Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia.

Authors:  M Esteller; S R Hamilton; P C Burger; S B Baylin; J G Herman
Journal:  Cancer Res       Date:  1999-02-15       Impact factor: 12.701

4.  CpG islands influence chromatin structure via the CpG-binding protein Cfp1.

Authors:  John P Thomson; Peter J Skene; Jim Selfridge; Thomas Clouaire; Jacky Guy; Shaun Webb; Alastair R W Kerr; Aimée Deaton; Rob Andrews; Keith D James; Daniel J Turner; Robert Illingworth; Adrian Bird
Journal:  Nature       Date:  2010-04-15       Impact factor: 49.962

5.  Repression of genes by DNA methylation depends on CpG density and promoter strength: evidence for involvement of a methyl-CpG binding protein.

Authors:  J Boyes; A Bird
Journal:  EMBO J       Date:  1992-01       Impact factor: 11.598

6.  A DNA hypermethylation module for the stem/progenitor cell signature of cancer.

Authors:  Hariharan Easwaran; Sarah E Johnstone; Leander Van Neste; Joyce Ohm; Tim Mosbruger; Qiuju Wang; Martin J Aryee; Patrick Joyce; Nita Ahuja; Dan Weisenberger; Eric Collisson; Jingchun Zhu; Srinivasan Yegnasubramanian; William Matsui; Stephen B Baylin
Journal:  Genome Res       Date:  2012-03-05       Impact factor: 9.043

Review 7.  Writing, erasing and reading histone lysine methylations.

Authors:  Kwangbeom Hyun; Jongcheol Jeon; Kihyun Park; Jaehoon Kim
Journal:  Exp Mol Med       Date:  2017-04-28       Impact factor: 8.718

8.  AOF1 is a histone H3K4 demethylase possessing demethylase activity-independent repression function.

Authors:  Ze Yang; Jun Jiang; M David Stewart; David M Stewart; Shankang Qi; Kenichi Yamane; Jiwen Li; Yi Zhang; Jiemin Wong
Journal:  Cell Res       Date:  2010-01-26       Impact factor: 25.617

9.  dKDM5/LID regulates H3K4me3 dynamics at the transcription-start site (TSS) of actively transcribed developmental genes.

Authors:  Marta Lloret-Llinares; Sílvia Pérez-Lluch; David Rossell; Tomás Morán; Joan Ponsa-Cobas; Herbert Auer; Montserrat Corominas; Fernando Azorín
Journal:  Nucleic Acids Res       Date:  2012-08-16       Impact factor: 16.971

Review 10.  Prominent role of histone lysine demethylases in cancer epigenetics and therapy.

Authors:  Avilala Janardhan; Chandrasekhar Kathera; Amrutha Darsi; Wajid Ali; Lingfeng He; Yanhua Yang; Libo Luo; Zhigang Guo
Journal:  Oncotarget       Date:  2018-01-25
View more
  4 in total

1.  Association of DNA methylation with steroidogenic enzymes in Cushing's adenoma.

Authors:  Takaya Kodama; Kenji Oki; Yu Otagaki; Ryuta Baba; Akira Okada; Kiyotaka Itcho; Kazuhiro Kobuke; Gaku Nagano; Haruya Ohno; Nobuyuki Hinata; Koji Arihiro; Celso E Gomez-Sanchez; Masayasu Yoneda; Noboru Hattori
Journal:  Endocr Relat Cancer       Date:  2022-06-29       Impact factor: 5.900

2.  IL-6 Promoter Hypomethylation Acts As a Diagnostic Biomarker in Hepatitis B Virus-Associated Hepatocellular Carcinoma.

Authors:  Jie-Ru Yang; Ju Wang; Hai-Ming Li; Shuai Gao; Yu-Chen Fan; Kai Wang
Journal:  Front Oncol       Date:  2022-03-11       Impact factor: 6.244

Review 3.  Alternative Splicing, Epigenetic Modifications and Cancer: A Dangerous Triangle, or a Hopeful One?

Authors:  Francisco Gimeno-Valiente; Gerardo López-Rodas; Josefa Castillo; Luis Franco
Journal:  Cancers (Basel)       Date:  2022-01-22       Impact factor: 6.639

4.  LncRNA affects epigenetic reprogramming of porcine embryo development by regulating global epigenetic modification and the downstream gene SIN3A.

Authors:  Daoyu Zhang; Yongfeng Zhou; Rong Huang; Yanhui Zhai; Di Wu; Xinglan An; Sheng Zhang; Lijing Shi; Qi Li; Xiangjie Kong; Hao Yu; Ziyi Li
Journal:  Front Physiol       Date:  2022-09-16       Impact factor: 4.755

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.